Recent developments in membrane targeting antifungal agents to mitigate antifungal resistance

Devashish Mehta; Varsha Saini; Avinash Bajaj

doi:10.1039/d3md00151b

journal article Jan 01, 2023

Recent developments in membrane targeting antifungal agents to mitigate antifungal resistance

Devashish Mehta

Varsha Saini

Avinash Bajaj

RSC Medicinal Chemistry Vol. 14 No. 9 pp. 1603-1628 · Royal Society of Chemistry (RSC)

View at Publisher Save 10.1039/d3md00151b

Abstract

Fungal infections cause severe and life-threatening complications especially in immunocompromised individuals.

Topics

No keywords indexed for this article. Browse by subject →

References

206

[1]

Rokas Nat. Microbiol. (2022) 10.1038/s41564-022-01112-0

[2]

Angiolella Microorganisms (2022) 10.3390/microorganisms10020409

[3]

Howell Br. J. Biomed. Sci. (2023) 10.3389/bjbs.2023.11314

[4]

Immune responses to human fungal pathogens and therapeutic prospects

Michail S. Lionakis, Rebecca A. Drummond, Tobias M. Hohl

Nature Reviews Immunology 2023 10.1038/s41577-022-00826-w

[5]

Burgess J. Fungi (2022) 10.3390/jof8080805

[6]

Netea Nat. Rev. Immunol. (2015) 10.1038/nri3897

[7]

Dunne Clin. Immunol. (2021) 10.1016/j.clim.2021.108734

[8]

Riley Crit. Care Nurs. Clin. North Am. (2021) 10.1016/j.cnc.2021.07.002

[9]

Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision

Felix Bongomin, Sara Gago, Rita Oladele et al.

Journal of Fungi 2017 10.3390/jof3040057

[10]

Polvi Cell. Mol. Life Sci. (2015) 10.1007/s00018-015-1860-z

[11]

Vanreppelen J. Fungi (2023) 10.3390/jof9020171

[12]

Cavassin Infect. Dis. Ther. (2021) 10.1007/s40121-020-00382-7

[13]

Malayeri J. Basic Res. Med. Sci. (2018) 10.29252/jbrms.5.2.48

[14]

Forsberg Med. Mycol. (2019) 10.1093/mmy/myy054

[15]

<p>Antimicrobial Resistance: Implications and Costs</p>

Porooshat Dadgostar

Infection and Drug Resistance 2019 10.2147/idr.s234610

[16]

Brown Clin. Infect. Dis. (2017) 10.1093/cid/ciw678

[17]

Dohmen J. Hosp. Infect. (2008) 10.1016/s0195-6701(08)60019-5

[18]

Balaban Nat. Rev. Microbiol. (2013) 10.1038/nrmicro3076

[19]

Candidiasis and Mechanisms of Antifungal Resistance

Somanon Bhattacharya, Sutthichai Sae-Tia, Bettina C. Fries

Antibiotics 2020 10.3390/antibiotics9060312

[20]

Chandrika Bioorg. Med. Chem. (2020) 10.1016/j.bmc.2020.115398

[21]

Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy

Gina Wall, Jose L. Lopez-Ribot

Antibiotics 2020 10.3390/antibiotics9080445

[22]

Vallières ACS Infect. Dis. (2020) 10.1021/acsinfecdis.0c00405

[23]

Zhang Appl. Microbiol. Biotechnol. (2021) 10.1007/s00253-021-11407-7

[24]

Izadi Mycoses (2022) 10.1111/myc.13477

[25]

Wu J. Med. Chem. (2017) 10.1021/acs.jmedchem.6b01203

[26]

Mishra Front. Microbiol. (2020) 10.3389/fmicb.2020.566325

[27]

Perfect Nat. Rev. Drug Discovery (2017) 10.1038/nrd.2017.46

[28]

Sant J. Appl. Microbiol. (2016) 10.1111/jam.13301

[29]

Lei Am. J. Transl. Res. (2019)

[30]

Basso J. Fungi (2020) 10.3390/jof6040241

[31]

Washton Diagn. Microbiol. Infect. Dis. (1989) 10.1016/0732-8893(89)90141-7

[32]

Hoffman Expert Opin. Invest. Drugs (2000) 10.1517/13543784.9.3.593

[33]

Peyton Drugs Today (2015) 10.1358/dot.2015.51.12.2421058

[34]

Alison J. Fungi (2020) 10.3390/jof6040373

[35]

Kabi Nanostruct. Biomater. (2022)

[36]

Martens Am. J. Obstet. Gynecol. (2022) 10.1016/j.ajog.2022.07.023

[37]

Bouz Pharmaceuticals (2021) 10.3390/ph14121312

[38]

Teixeira Pharmaceuticals (2022) 10.3390/ph15111427

[39]

Carolus J. Fungi (2020) 10.3390/jof6040321

[40]

Zotchev Curr. Med. Chem. (2003) 10.2174/0929867033368448

[41]

Worthen Drug Dev. Ind. Pharm. (2001) 10.1081/ddc-100103727

[42]

Chandrasekar J. Antimicrob. Chemother. (2011) 10.1093/jac/dkq479

[43]

Qiu Guoji Yanke Zazhi (2015)

[44]

Amphotericin primarily kills yeast by simply binding ergosterol

Kaitlyn C. Gray, Daniel S. Palacios, Ian Dailey et al.

Proceedings of the National Academy of Sciences 2012 10.1073/pnas.1117280109

[45]

Kamiński Eur. Biophys. J. (2014) 10.1007/s00249-014-0983-8

[46]

Baginski Biochim. Biophys. Acta, Biomembr. (2002) 10.1016/s0005-2736(02)00581-3

[47]

Hamill Drugs (2013) 10.1007/s40265-013-0069-4

[48]

Szymański J. Enzyme Inhib. Med. Chem. (2022) 10.1080/14756366.2022.2050224

[49]

Grover Indian J. Pharmacol. (2010) 10.4103/0253-7613.62396

[50]

Hüttel Appl. Microbiol. Biotechnol. (2021) 10.1007/s00253-020-11022-y

Showing 50 of 206 references

Metrics

31

Citations

206

References

Details

Published: Jan 01, 2023
Vol/Issue: 14(9)
Pages: 1603-1628
License: View

Authors

D

Devashish Mehta

Laboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, Faridabad-121001, Haryana, India

V

Varsha Saini

Laboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, Faridabad-121001, Haryana, India

A

Avinash Bajaj

Laboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, Faridabad-121001, Haryana, India

Funding

Indian Council of Medical Research Award: Myco/Fell/11/2022ECD-II

Regional Centre for Biotechnology

Cite This Article

Devashish Mehta, Varsha Saini, Avinash Bajaj (2023). Recent developments in membrane targeting antifungal agents to mitigate antifungal resistance. RSC Medicinal Chemistry, 14(9), 1603-1628. https://doi.org/10.1039/d3md00151b

Recent developments in membrane targeting antifungal agents to mitigate antifungal resistance

You May Also Like